Literature DB >> 2891941

Staphylococcal sepsis. The changing pattern of disease and therapy.

S J Eykyn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2891941     DOI： 10.1016/s0140-6736(88)90294-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.

Authors:  M C Raviglione; J F Boyle; P Mariuz; A Pablos-Mendez; H Cortes; A Merlo
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes.

Authors:  E Mattsson; H Van Dijk; J Verhoef; R Norrby; J Rollof
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.

Authors:  C P Timmerman; E Mattsson; L Martinez-Martinez; L De Graaf; J A Van Strijp; H A Verbrugh; J Verhoef; A Fleer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

4.  Staphylococcus aureus septic arthritis in patients on hemodialysis treatment.

Authors:  S Slaughter; R J Dworkin; D N Gilbert; J E Leggett; S Jones; R Bryant; M A Martin
Journal:  West J Med       Date:  1995-08

Review 5.  Infections due to antibiotic-resistant gram-positive cocci.

Authors:  G M Caputo; M Singer; S White; M R Weitekamp
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

6.  Susceptibility testing of bacteria recovered from patients with peritonitis complicating continuous ambulatory peritoneal dialysis.

Authors:  H Ludlam; L Johnston; P Hopkins
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

7.  Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors.

Authors:  E Mattsson; J Rollof; J Verhoef; H Van Dijk; A Fleer
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

8.  Subcutaneous gentamicin injection around the cuff in treatment of resistant exit site infection in peritoneal dialysis patients: a pilot study.

Authors:  Oguzhan Sıtkı Dizdar; Ozerhan Ozer; Selahattin Erdem; Ali Ihsan Gunal
Journal:  Ther Clin Risk Manag       Date:  2017-07-20       Impact factor: 2.423
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.